The European Journal of Internal Medicine published a study that found 93.7% of seniors benefited from cannabis treatment.
During the study period 2736 patients above 65?years of age began cannabis treatment and answered the initial questionnaire.
The mean age was 74.5?±?7.5?years.
The most common indications for cannabis treatment were pain (66.6%) and cancer (60.8%).
After six months of treatment 93.7% of the respondents reported improvement in their condition and the reported pain level was reduced from a median of 8 on a scale of 0-10 to a median of 4.
Most common adverse events were: dizziness (9.7%) and dry mouth (7.1%).
After six months 18.1% stopped using opioid analgesics or reduced their dose.